Clinical Trials
3
0 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
N/A
Completed
3
100.0%
No approval data available
- The FDA authorized 20 ZYN nicotine pouch products to carry a modified-risk claim stating they pose lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis compared to cigarettes. - A 2023 randomized controlled study found that smokers switching to nicotine pouches reduced harmful chemical exposure by approximately 42% to 96% within one week, comparable to quitting nicotine entirely. - The authorization applies only to adults who completely switch from cigarettes; the FDA stresses that no tobacco product is safe and full cessation remains the best health option. - Global retail sales of nicotine pouches reached 23.4 billion units in 2024, a more than 50% increase from the prior year, underscoring rapid category growth.
- The FDA has authorized Swedish Match's ZYN nicotine pouches, marking the first approval for this type of product as a safer alternative to traditional tobacco products. - This decision aligns with Philip Morris International's strategy to create a smoke-free future by offering alternatives to cigarettes for adults over 21. - The approved ZYN pouches come in various flavors and nicotine strengths (3mg and 6mg), providing options for smokers looking to switch to less harmful products. - Swedish Match North America emphasizes ZYN's potential role in protecting public health by helping people transition away from cigarettes and other traditional tobacco products.
- The FDA has renewed the modified risk orders for eight General Snus products from Swedish Match USA Inc., allowing them to continue being marketed with a reduced-risk claim. - These snus products are authorized to claim that using them instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. - The renewal allows Swedish Match to continue marketing these products with the modified risk claim, a practice that has been in place since the initial authorization in 2019. - The authorized products include various General Snus offerings, such as General Loose, General Mint Portion White Large, and General Wintergreen Portion White Large.
